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SUMMARY: In the last few decades, the prevalence of allergic dis-
eases, asthma, allergic rhinoconjunctivitis and atopic dermatitis in 
particular, has been observed to increase in urban settings. In ad-
dition, epidemiological data show the proportion of overweight indi-
viduals to rise in the last two decades. Obesity and overweight are 
a major public health problem not only in industrialized countries but 
also in developing ones because the morbidity and mortality rates are 
greater in the obese. An increased body mass index is considered 
a risk factor for the occurrence of myocardial infarction, stroke, ath-
erosclerosis, hypertension, insulin resistance, dyslipidemia and some 
types of carcinoma. An ever greater body of available data point to the 
possible association of allergic diseases with obesity and overweight. 
Impaired immune tolerance is considered to be a sequel of immune 
changes due to the activity of adipokines, bioactive molecules secret-
ed in white adipose tissue. About 50 adipokines are currently known 
to be secreted in adipose tissue, some of them belonging to the group 
of cytokines such as tumor necrosis factor α and interleukin-6. The 
association between obesity and allergic diseases has not yet been 
fully clarified. While the observations recorded to date should not be 
neglected, additional studies are necessary to help understand the 
complex function of adipokines involved in allergic events.
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INTRODUCTION
In the last few decades, the prevalence of aller-
gic diseases such as allergic asthma (AA), allergic 
rhinoconjunctivitis (AR) and atopic dermatitis (AD) 
has been observed to increase, in urban settings 
in particular. The factors contributing to this rising 
pattern have not yet been fully elucidated, how-
ever, a number of potential causes have been im-
plicated, including ever greater environmental pol-
lution, exposure to “newly emerging” allergens for 
the human immune system, formation of so-called 
allergen conglomerates through allergen interac-
tion with contaminated atmosphere, prolonged 
stay indoors, sedentary work, inadequate physical 
activity, and stressful lifestyle (1). Recently, ever 
more data point to the possible association of al-
lergic diseases with obesity and overweight.
ALLERGIC DISEASES ON AN 
INCREASE
Data from western countries show an increase 
in the prevalence of AD, e.g., of 7%-21% in school-
children from different areas of the USA (2,3) and 
15.8% in New Zealand (4). In a Munich study, 
the cumulative prevalence of AD in children aged 
232 ACTA DERMATOVENEROLOGICA CROATICA
≤2 years was 21.5% (5), whereas a study in pre-
school children from two towns in Sweden yielded 
a cumulative AD incidence of 20.7% versus 15% 
recorded in the same area 5 years before (6). A 
study carried out in Denmark that included chil-
dren aged 12-16 years showed a total AD preva-
lence of 21.3% and one-year prevalence of 6.7% 
(7). In Copenhagen, the cumulative incidence in 
two-year-old children was as high as 41% (8).
AR is also on an increase, with 20%-30% of 
the population suffering from this allergic disease 
worldwide (1). The same holds for the prevalence 
of AA, which shows a disturbing rise in children in 
particular. In the USA, the prevalence of AA in chil-
dren increased from 3.6% in the 1980s to 8.9% in 
2005 (9). In Denmark, 6.9% of children suffer from 
AA, and as many as 15.7% of children have some 
symptoms of AR (7).
Results of a study performed in 2003 in 18 
Zagreb elementary schools as part of the Interna-
tional Study of Asthma and Allergies in Childhood 
(ISAAC) showed the City of Zagreb to have a rela-
tively low prevalence of allergic diseases relative 
to other countries. The study included 1047 chil-
dren aged 10 years. The 12-month prevalence of 
AA, AR and AD was 6.02%, 12.13% and 7.83%, 
respectively (10).
OBESITY AND OVERWEIGHT
In the last two decades, the increase in the 
prevalence of allergic diseases has been paral-
leled by a growing proportion of the obese and 
overweight in the general population. The World 
Health Organization (WHO) has issued a warn-
ing on obesity to becoming the leading challenge 
in the 21st century, as the proportion of obese 
persons shows a very disturbing increase. The 
morbidity and mortality rates are greater in the 
obese than in those with normal body weight. An 
elevated body mass index (BMI) poses a risk of 
myocardial infarction, stroke, atherosclerosis, in-
sulin resistance (11), hypertension (12), Crohn’s 
disease (13), and some types of carcinoma (14). 
Obesity and overweight pose a problem in both in-
dustrialized and developing countries. In Croatia, 
there are more than 20% (n=720,000) of obese 
individuals, along with 43% of male and 34% of 
female overweight persons. In 2003, the mean 
BMI in Croatia was 29.93 kg/m2 (15). According to 
WHO data, one third of the world population are 
obese. In some European countries, the propor-
tion of obese persons is lower than that recorded 
in Croatia, i.e. in Austria 10% of male and 14% of 
female, in France 11% of male and female, and in 
Spain 12% of male and 15% of female individu-
als. In Greece, however, obesity is found in as 
many as 28% of male and 38% of female popula-
tion (15). In the USA, obesity and overweight also 
pose a major public health problem. Data on the 
1999-2002 period show the prevalence of obese 
persons to exceed 30.5%, while the prevalence of 
overweight was 64.5%, with more than 4.7% of ex-
tremely overweight and BMI >40 kg/m2 (16). Data 
on 10% of obese children worldwide and even 
16% in the USA cause great concern, especially 
in conjunction with the fact that 30% of children in 
the USA are overweight and at risk of developing 
obesity (15,16).
BODY MASS INDEX
The main characteristic of obesity is excessive 
deposition of subcutaneous and visceral adipose 
tissue. Body mass index (BMI), also known as 
Quetelet index, is an alternative fatty tissue mea-
sure showing the body mass (kg) to body height 
(m2) ratio. BMI has been used since the 19th cen-
tury, when it was defined by the mathematician 
Lambert Adolphe Jacques Quetelet, based on the 
assumption on BMI to be age, sex and race inde-
pendent. However, anthropometric and hydroden-
sitometric measurements using the method of tri-
tium dilution monitoring and dual-photon absorp-
tion have subsequently showed the percentage of 
adipose tissue to be greater in elderly and female 
individuals (17). Yet, BMI has continued to be 
used in epidemiological studies, since additional 
measurements cannot be implemented in large 
studies, while novel methods are rather expen-
sive and occasionally require the use of radiologic 
techniques. Individuals with BMI of 25.0-29.9 kg/
m2 are considered to be overweight and those with 
BMI exceeding 30.0 kg/m2 are obese.
ADIPOSE TISSUE AS AN ENDOCRINE 
ORGAN
Adipose tissue was considered as an energy 
reservoir until the discovery of leptin, a bioactive 
molecule structurally similar to cytokines, in 1994 
(18). Nowadays, it is known that about 50 bioac-
tive molecules are secreted in adipose tissue, 
which is therefore considered as an endocrine 
organ. Some of these molecules belong to cyto-
kines, such as tumor necrosis factor α (TNF-α), in-
terleukin-6 (IL-6) and interleukin-8 (IL-8); however, 
some molecules such as leptin and adiponectin do 
not have a cytokine structure. Thus, the previously 
used term “adipocytokines” has been substituted 
by the term “adipokines” (19). White adipose tis-
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sue consists predominantly of adipocytes, and 
of connective tissue matrix, nervous tissue and 
stromal vascular cells (18). Analysis have shown 
that CD14+ and CD31+ macrophages account for 
some 10% of the stromal vascular fraction, their 
number being directly dependent on the amount 
of adipose tissue (20).
Besides the adipokines mentioned above, the 
following ones are also secreted in adipose tis-
sue: growth factors such as transforming growth 
factor β (TGF-β); complement factors such as 
adipsin; blood pressure regulatory factors such 
as angiotensinogen; lipid metabolism factors; glu-
cose homeostasis factors including adiponectin; 
angiogenesis factors; and probably an increasing 
number of adipokines in the future (18). Proinflam-
matory cytokines account for the major part of ac-
tive molecules secreted in adipose tissue of obese 
persons. These cytokines are then released to the 
circulation maintaining the state of so-called mild 
inflammation. This subclinical proinflammatory 
state is responsible for all metabolic and cardio-
vascular alterations accompanying metabolic syn-
drome (21,22). Adiponectin is the only adipokine 
demonstrated to have an anti-inflammatory action; 
also, its secretion is known to decrease with fatty 
tissue accumulation (23). According to studies 
pointing to the possible association of obesity and 
allergic diseases, the reduced immune tolerance 
is considered to be consequential to the immune 
changes caused by the action of adipokines (24).
TNF-α is the most extensively investigated cyto-
kine which is known to steer the functions of some 
other cytokines. TNF-α is secreted by adipocytes 
and stromal vascular cells, mostly in subcutaneous 
and to a minor extent in visceral adipose tissue. 
The mRNA for its TNF-R1 and TNF-R2 receptors 
is known to be secreted in adipose tissue. TNF-α 
is characterized by marked pleiotropic action, as 
there are more than 20 TNF-α receptors. It directly 
influences the secretion of IL-6 (25). According to 
some reports, TNF-α increases the T helper type 
2 lymphocyte (Th-2) production of cytokines such 
as IL-4 and IL-5, thus being directly involved in the 
mechanisms of early hypersensitivity (24,26).
IL-6 secretion in the circulation correlates posi-
tively with fatty tissue deposits. It is considered that 
30% of IL-6 is secreted exclusively in adipose tis-
sue. IL-6 modifies glucose tolerance, aggravates 
insulin resistance (18), and stimulates hepatic pro-
duction of C-reactive protein (CRP) (19). As part 
of its immune activity, IL-6 is known to stimulate B 
lymphocytes for the production of antibodies (27). 
DISCUSSION
A number of recent epidemiological studies 
indicate the incidence of atopic diseases to be 
higher in obese than in normal weight individuals. 
In a prospective study conducted in the USA in 
the population of nurses aged 26-46, increased 
BMI after age 18 was associated with a greater 
incidence of allergic asthma (28). As this study 
included exclusively female population, there are 
no data on the possible sex differences. In a Ca-
nadian study that included both male and female 
subjects aged 20-64, obesity was associated with 
the development of asthma in women but not in 
men (29). One of the reasonable explanations 
for such a pattern may be found in the greater 
percentage of adipose tissue in women as com-
pared with men with the same BMI. In addition, 
female sex hormones, progesterone and estrogen 
in particular, may have a role in the etiology of 
asthma. Progesterone and estrogen are secreted 
in adipose tissue (21). The 17 β-estradiol, which 
is considered to act as a strong modulator of IL-
4 secretion, was found to be elevated in a group 
of healthy but obese women. Adipose tissue is 
considered to contain an array of steroidogenic 
enzymes involved in the synthesis of estrogen. 
Testosterone aromatization to estradiol was also 
observed to be greater in obese than in normal 
weight women (30). In postmenopausal women 
receiving hormone replacement therapy (HRT), 
the incidence of asthma was found to be twofold 
that in their non-HRT counterparts, thus clearly 
pointing to estrogen involvement in the etiology 
of asthma (31). A similar study including subjects 
of both sexes and relatively younger age groups 
(age 18-30) also showed an association between 
increased body weight and asthma in women but 
not in men (32). In contrast to these reports, re-
sults of a study carried out in Atlanta, USA, indi-
cated an association of BMI and asthma, with the 
incidence of asthma being comparable in the two 
sexes (33). The more so, a study from California, 
USA, which included children of both sexes aged 
7-18, showed the risk of asthma to be greater in 
male than in female children (34).
The association of BMI and atopy has also 
been investigated. In a study from Munich in chil-
dren aged 4-17, the rate of positive prick tests to 
nutritive and inhalation allergens was considerably 
higher in children with higher BMI. There was no 
sex difference (35). On the contrary, a study per-
formed in Arizona, USA, an association of BMI and 
hypersensitivity was demonstrated in female but 
not in male children. Positive prick test to at least 
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one allergen was recorded in 54.2% of female chil-
dren having put on weight versus 35.9% of female 
children without weight gain (36). Similar results 
have also been reported from a Taiwan study (37). 
A study of atopy in healthy but obese women re-
vealed threefold levels of specific IgE to particular 
allergens while the levels of total IgE were not in-
creased in comparison with control group subjects, 
thus demonstrating direct association between 
obesity and Th-2 immune response (30).
Some studies failed to demonstrate an asso-
ciation between obesity and asthma. One of these 
was a study from England that included children 
aged 8 and 9 (38). In a study from New Zealand, 
no such association was found in childhood but it 
did emerge in late adolescence to rise consider-
ably by the age 26 (39). It should be noted that 
the above mentioned study in England (38) was 
launched in the early 1970s, when the associa-
tion of obesity and allergic diseases had not yet 
been so pronounced; thus, it is rather considered 
a phenomenon characteristic of the last 2-3 de-
cades (40). 
CONCLUSION
The association of obesity and allergic diseases 
has not yet been fully clarified. The observations 
and findings reported to date should by no means 
be neglected, while additional research is neces-
sary to improve the understanding of the complex 
function of adipokines involved in allergic events.
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